Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,708 public trials 1,048 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

NCT01712217

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic-Scottsdale Scottsdale, Arizona, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 65 locations
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

NCT03819387

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Toledo, Eleanor N. Dana Cancer Center Toledo, Ohio, United States
View Trial Details
Completed

A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients

NCT03485326

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Beijing, China
  • Research Site Chengde, China
  • Research Site Chengdu, China
  • Research Site Dingzhou, China
View all 29 locations
View Trial Details
Completed

Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer

NCT04732520

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Prince of Wales Hospital Shatin, Hong Kong
  • Radboud University Medical Center Nijmegen, Netherlands
  • Fundacion Instituto de Investigation Sanitaria de la Fundacion Jimenez Diaz Madrid, Spain
  • Hospital Universitario de Salamanca Salamanca, Spain
View Trial Details
Completed

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

NCT04194203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital; Oncology Department Beijing, China
  • the First Hospital of Jilin University Changchun, China
View all 23 locations
View Trial Details

Related conditions